ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
Alpha Tau Medical Ltd

Alpha Tau Medical Ltd (DRTS)

3.53
0.00
(0.00%)
終了 2月4日 6:00AM
0.00
0.00
(0.00%)
取引時間後: -

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
3.53
買値
3.30
売値
3.50
出来高
-
0.00 日の範囲 0.00
1.75 52 週間の範囲 4.3866
時価総額
前日終値
3.53
始値
-
時刻
最終取引時間
-
財務取引量
-
VWAP
-
平均取引量 (3 か月)
89,369
発行済株式数
69,670,612
配当利回り
-
PER
-8.43
1 株当たり利益 (EPS)
-0.42
歳入
-
純利益
-29.16M

Alpha Tau Medical Ltd について

Alpha Tau Medical focuses on R&D, and commercialization of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer tumors. The Alpha DaRT technology was developed in 2003 at Tel Aviv University. Alpha Tau Medical focuses on R&D, and commercialization of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer tumors. The Alpha DaRT technology was developed in 2003 at Tel Aviv University.

セクター
Surgical,med Instr,apparatus
業界
Surgical,med Instr,apparatus
ウェブサイト
本社
Jerusalem, Jerusalem, Isr
設立
-
Alpha Tau Medical Ltd is listed in the Surgical,med Instr,apparatus sector of the ナスダック市場 with ticker DRTS. The last closing price for Alpha Tau Medical was US$3.53. Over the last year, Alpha Tau Medical shares have traded in a share price range of US$ 1.75 to US$ 4.3866.

Alpha Tau Medical currently has 69,670,612 shares in issue. The market capitalisation of Alpha Tau Medical is US$245.94 million. Alpha Tau Medical has a price to earnings ratio (PE ratio) of -8.43.

DRTS 最新ニュース

Alpha Tau Announces FDA Approval of IDE Supplement to Expand Pilot Trial of Alpha DaRT® to Thirty Patients with Pancreatic Cancer in Two Cohorts, with Locally Advanced or Metastatic Disease

JERUSALEM, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

Alpha Tau Announces Cornerstone Interim Data Across Multiple Clinical Trials to be Shared at R&D Update Day

- High disease control rate and strong interim safety results observed in pancreatic cancer patients across three trials exploring the use of Alpha DaRT® - - Ad-hoc analyses of pancreatic cancer...

Alpha Tau Announces Upcoming Presentation of New Data at 2025 ASCO GI Symposium and at Company R&D Update Day

JERUSALEM, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

Alpha Tau Announces Appointment of Maya Netser to its Board of Directors; Board Member Meir Jakobsohn Stepping Down, Staying on as Advisor

JERUSALEM, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW), ("Alpha Tau" or the "Company"), the developer of the innovative alpha-radiation cancer therapy Alpha...

Alpha Tau to Present at the 43rd Annual J.P. Morgan Healthcare Conference

JERUSALEM, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

Alpha Tau to Participate in Ladenburg’s Oncology Innovators & Investors Symposium

JERUSALEM, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

Alpha Tau Medical Announces Third Quarter 2024 Financial Results and Provides Corporate Update

- Alpha DaRT® accepted into the prestigious Total Product Life Cycle Advisory Program (TAP) of the FDA, to accelerate market access to the Alpha DaRT® for patients with recurrent glioblastoma...

Alpha Tau to Participate in Citi’s 2024 Global Healthcare Conference and Piper Sandler’s 36th Annual Healthcare Conference

JERUSALEM, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

Alpha Tau Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma Multiforme

JERUSALEM, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-emitters cancer therapy Alpha...

Alpha Tau Treats First Patient with Recurrent Lung Cancer

JERUSALEM, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.67-15.95238095244.24.2283.391837973.7132065CS
40.3611.3564668773.174.38663.131811213.78986374CS
121.3159.0090090092.224.38662.14893693.44804285CS
261.4368.09523809522.14.38661.93522883.15229468CS
520.195.688622754493.344.38661.75433762.92212672CS
156-8.02-69.437229437211.5520.651.75947398.58995001CS
260-8.02-69.437229437211.5520.651.75947398.58995001CS

DRTS - Frequently Asked Questions (FAQ)

What is the current Alpha Tau Medical share price?
The current share price of Alpha Tau Medical is US$ 3.53
How many Alpha Tau Medical shares are in issue?
Alpha Tau Medical has 69,670,612 shares in issue
What is the market cap of Alpha Tau Medical?
The market capitalisation of Alpha Tau Medical is USD 245.94M
What is the 1 year trading range for Alpha Tau Medical share price?
Alpha Tau Medical has traded in the range of US$ 1.75 to US$ 4.3866 during the past year
What is the PE ratio of Alpha Tau Medical?
The price to earnings ratio of Alpha Tau Medical is -8.43
What is the reporting currency for Alpha Tau Medical?
Alpha Tau Medical reports financial results in USD
What is the latest annual profit for Alpha Tau Medical?
The latest annual profit of Alpha Tau Medical is USD -29.16M
What is the registered address of Alpha Tau Medical?
The registered address for Alpha Tau Medical is KIRYAT HAMADA ST. 5, JERUSALEM, JERUSALEM, 9777605
What is the Alpha Tau Medical website address?
The website address for Alpha Tau Medical is www.alphatau.com
Which industry sector does Alpha Tau Medical operate in?
Alpha Tau Medical operates in the SURGICAL,MED INSTR,APPARATUS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
AALAmerican Airlines Group Inc
US$ 16.70
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 73.51
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.74
(0.00%)
0
AACGATA Creativity Global
US$ 0.78
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 16.70
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 73.51
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.74
(0.00%)
0
AACGATA Creativity Global
US$ 0.78
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 16.70
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 73.51
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.74
(0.00%)
0
AACGATA Creativity Global
US$ 0.78
(0.00%)
0

DRTS Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock